The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives
Open accessAbstract
Interstitial cystitis/bladder pain syndrome is a debilitating condition of unknown etiology characterized by persistent pelvic pain with lower urinary tract symptoms and comprises a wide variety of potentially clinically useful phenotypes with different possible etiologies. Current clinicopathological and genomic evidence suggests that interstitial cystitis/bladder pain syndrome should be categorized by the presence or absence of Hunner lesions, rather than by clinical phenotyping based on symptomatology. The Hunner lesion subtype is a distinct inflammatory disease with proven bladder etiology characterized by epithelial denudation and enhanced immune responses frequently accompanied by clonal expansion of infiltrating B cells, with potential engagement of infection. Meanwhile, the non‐Hunner lesion subtype is a non‐inflammatory disorder with little evidence of bladder etiology. It is potentially associated with urothelial malfunction and neurophysiological dysfunction, and frequently presents with somatic and/or psychological symptoms, that commonly result in central nervous sensitization. Animal models of autoimmune cystitis and neurogenic sensitization might serve as disease models for the Hunner lesion and non‐Hunner lesion subtypes, respectively. Here, we revisit the taxonomy of interstitial cystitis/bladder pain syndrome according to current research, and discuss its potential pathophysiology and representative animal models. Categorization of interstitial cystitis/bladder pain syndrome based on cystoscopy is mandatory to design optimized treatment and research strategies for each subtype. A tailored approach that specifically targets the characteristic inflammation and epithelial denudation for the Hunner lesion subtype, or the urothelial malfunction, sensitized/altered nervous system and psychosocial problems for the non‐Hunner lesion subtype, is essential for better clinical management and research progress in this complex condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If acute inflammation is not resolved, chronic inflammatory cells may infiltrate into the suburothelium and the detrusor muscle, resulting in pan-cystitis and chronic scar formation [8].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [8]
In the citing paper
“Patients with NHIC often have multiple associated organ complaints, including gastroesophageal reflux disease, myofascial pain, insomnia, depression, and anxiety [8].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [8]
In the citing paper
“Therefore, intravesical BoNT-A injection is recommended in the clinical guidelines and regarded a standard fourth-line treatment for IC/BPS [8].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment
Hanno, P. M., Erickson, D., Moldwin, R., & Faraday, M. M. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.01.086 · Cited by 692
Self-citationIncreased mast cells in the irritable bowel syndrome
O’Sullivan, Clayton, Breslin, Harman, Bountra, Mclaren, & O’Morain (2000) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2000.00221.x · Cited by 480
Terminal ileal mucosal mast cells in irritable bowel syndrome
Weston, A. P., Biddle, W. L., Bhatia, P. S., & Miner, P. B. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303164 · Cited by 338
Possible pathophysiology of ketamine‐related cystitis and associated treatment strategies
Jhang, J., Hsu, Y., & Kuo, H. (2015) · International Journal of Urology · doi:10.1111/iju.12841 · Cited by 106
Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1
Ito, A., Hagiyama, M., & Oonuma, J. (2008) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.44.83 · Cited by 48
Alexithymia and anesthetic bladder capacity in interstitial cystitis/bladder pain syndrome
Chiu, C.-D., Lee, M.-H., Chen, W.-C., Ho, H. L., & Wu, H.-C. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.06.019 · Cited by 19
Cited by
Yu, W.-R., Jhang, J.-F., Jiang, Y.-H., & Kuo, H.-C. (2024) · Biomedicines · doi:10.3390/biomedicines12092051 · Cited by 39
Metadata
- Authors
- Akiyama, Y., Luo, Y., Hanno, P. M., Maeda, D., & Homma, Y.
- Venue
- International Journal of Urology
- Publisher
- Wiley
- Published
- 2020-04-04
- Volume
- 27
- Issue
- 6
- Pages
- 491-503
- ISSN
- 0919-8172 (ISSN-L)
- 1442-2042
- OpenAlex
- W3014604613
- Cited by
- 179
- References
- 6
- FWCI
- 22.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives. https://app.cochat.ai/papers/10.1111/iju.14229
- The paper
- Akiyama, Y., Luo, Y., Hanno, P. M., Maeda, D., & Homma, Y. (2020). Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives. International Journal of Urology. https://doi.org/10.1111/iju.14229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.